In a patient receiving an unfractionated heparin infusion for renal infarction who now has a markedly supratherapeutic activated partial thromboplastin time, what is the next step in management?

Immediately Stop the Heparin Infusion

For a patient on heparin infusion with a PTT of 134 seconds (markedly supratherapeutic), the next step is to immediately stop the heparin infusion and recheck the PTT in 4 hours. 1, 2, 3

Management Algorithm

Immediate Actions

1. Discontinue the heparin infusion immediately 1, 3

   • The short half-life of unfractionated heparin (60-120 minutes) means that simply stopping the infusion is usually sufficient for most cases without active bleeding 1
   • Do NOT restart until PTT returns to therapeutic range

2. Assess for bleeding complications 1, 3

   • Examine for signs of hemorrhage (intracranial, gastrointestinal, urinary tract, retroperitoneal)
   • Check vital signs for hemodynamic instability
   • Monitor for occult bleeding sites

3. Recheck PTT in 4 hours 2, 3

   • This timing aligns with heparin's clearance kinetics
   • Target therapeutic range: PTT 1.5-2.0 times control (approximately 60-85 seconds) or anti-Xa 0.35-0.70 IU/mL 2, 4, 3

If Active Bleeding is Present

Protamine sulfate is indicated ONLY if there is active bleeding 1, 5, 6, 5:

• Dosing: 1 mg protamine per 100 units of heparin given in the previous 2-3 hours 5, 6, 5
• Maximum single dose: 50 mg 5
• Administration: Slow IV injection over 10 minutes (not exceeding 5 mg/min to avoid hypotension) 6
• If PTT remains elevated after initial dose: Give repeat dose of 0.5 mg protamine per 100 units of heparin 5

Important Caveats

Do NOT give protamine if anti-Xa activity is <0.2 IU/mL 1 - this indicates minimal residual heparin effect and protamine would be unnecessary.

For non-bleeding patients with supratherapeutic PTT 1:

• Simply stopping the infusion is sufficient
• Confirm absence of overdosage by measuring anti-Xa activity if available
• The PTT of 134 represents approximately 2.7 times control (assuming control ~50 seconds), which is above the therapeutic range but termination of infusion should suffice

Restarting Heparin

Once PTT returns to therapeutic range (60-85 seconds):

• Resume at a reduced infusion rate (typically decrease by 10-15%) 2
• Recheck PTT 4 hours after rate change 2, 3
• Continue monitoring until stable therapeutic anticoagulation achieved

Monitoring Considerations

The discordance between PTT and anti-Xa levels is common 7, 8, 9. If available, anti-Xa assay (target 0.35-0.70 IU/mL) is preferred over PTT for monitoring 2, 10 as it's less affected by:

• Factor VIII elevations (which prolong PTT disproportionately)
• Factor II deficiency
• Lupus anticoagulants
• Other coagulation factor abnormalities

This patient likely received too high an initial dose or has factors affecting heparin clearance (renal function, antithrombin levels). The key is that stopping the infusion addresses the immediate risk without requiring reversal agents in the absence of bleeding 1.